[ij] [ij] [ij] 
Email id

Asian Journal of Pharmaceutical Analysis
Year : 2020, Volume : 10, Issue : 4
First page : ( 207) Last page : ( 212)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.5958/2231-5675.2020.00038.1

Method development and validation of stability indicating rp-hplc for the estimation of felodipine pr tablets

Bhavana G*, Indira Priyadarshini G, Apuroopa

Department of Pharmaceutical Analysis, Hindu College of Pharmacy, Amaravathi Road, Guntur-522002, A. P., India

*Corresponding Author E-mail: bhavana.hcop@gmail.com

Online published on 27 April, 2021.


The aim of the present work is to develop a new, simple, sensitive, accurate and analytical method of developing and validating the stability indicating estimation of felodipine in pharmaceutical tablet dosage form using RP-HPLC. The API was supplied by Aurobindo Pharma Ltd, Hyderabad. The chromatographic separation was done with Inertsil ODS _2 C_18 (100 × 4.6mm, 3μ) using HPLC Shimadzu (2010 CHT) instrument with LC solutions software. The suitable wavelength for the determination of felodipine is 238nm where it gave a good sensitivity for the assay using UV-Visible spectrophotometer. The mobile phase was optimized to Buffer: Acetonitrile: Methanol in proportion 2:2:1 v/v respectively. The method was performed with flow rates 1ml/min. Temperature was maintained at Ambient. Standard deviation and %RSD were calculated and obtained as 0.3% respectively. LOD and LOQ were found to be 0.56μg/ml, 1.71μg/ml respectively. The Accuracy i.e, %Recovery for 50, 100 and 150% levels are obtained as 98.13%, 99.56%, 98.52% respectively. The % degradation results were within the limits and the method was validated.



Felodipine, RP-HPLC, RSD, LOD and LOQ.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
738,989,571 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.